Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Triple-negative breast cancer (TNBC) is classically defined by estrogen receptor (ER) and progesterone receptor (PR) immunohistochemistry expression <1% and absence of HER2 amplification/overexpression. HER2-negative breast cancer with low ER/PR expression (1–10%) has a gene expression profile si...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoder, Rachel, Kimler, Bruce F., Staley, Joshua M., Schwensen, Kelsey, Wang, Yen Y., Finke, Karissa, O’Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Stecklein, Shane R., Godwin, Andrew K., Khan, Qamar J., Sharma, Priyanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273627/
https://www.ncbi.nlm.nih.gov/pubmed/35817765
http://dx.doi.org/10.1038/s41523-022-00448-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273627/
https://www.ncbi.nlm.nih.gov/pubmed/35817765
http://dx.doi.org/10.1038/s41523-022-00448-4

Ejemplares similares